• NEBANNER

Ƙananan MOQ don Siyarwa mai zafi!Samar da Masana'antu Babban Ingancin Betrixaban Raw Materials CAS 330942-05-7

Ƙananan MOQ don Siyarwa mai zafi!Samar da Masana'antu Babban Ingancin Betrixaban Raw Materials CAS 330942-05-7

Takaitaccen Bayani:


Cikakken Bayani

Tags samfurin

Don zama matakin tabbatar da mafarki na ma'aikatan mu!Don gina farin ciki, ƙarin haɗin kai da ƙarin ƙwararrun ƙungiyar!Don samun lada tare da masu siyayya, masu siyarwa, jama'a da kanmu don Low MOQ don Siyarwa mai zafi!Samar da Factory High Quality Betrixaban Raw Materials CAS 330942-05-7, Mu masu gaskiya ne kuma bude.Muna sa ido ga tsayawa ta hanyar kafa amintacciyar dangantakar soyayya mai dorewa.
Don zama matakin tabbatar da mafarki na ma'aikatan mu!Don gina farin ciki, ƙarin haɗin kai da ƙarin ƙwararrun ƙungiyar!Don samun ladan juna na masu siyayya, masu kaya, jama'a da kanmuChina Pharmaceutical Matsakaicin da 330942-05-7, "Kyakkyawan inganci da farashi mai kyau" sune ka'idodin kasuwancin mu.Idan kuna sha'awar mafitarmu ko kuna da wasu tambayoyi, ku tuna don jin daɗin tuntuɓar mu.Muna fatan kulla alakar hadin gwiwa da ku nan gaba kadan.

Ayyukan Halittu Fondaparinux

Bayyana Fondaparinux sodium shine mai hanawar Xa inhibitor mai dogaro da thrombin.
Masu alaƙaCategories Hanyar sigina >> Metabolic enzymes/proteases >> Factor Xa Bincike yankunan >> cututtuka na zuciya da jijiyoyin jini
manufa Factor Xa[1]
In vitrokaratu Fondaparinux sodium shine farkon sabon maganin ƙwanƙwasa wanda ke zaɓen factor Xa.Don Fondaparinux, ƙimar IC50 (anti-Xa IU / ml) na monocytes da aka kunna (ac-M) shine 0.59 ± 0.05, kuma ƙwayoyin da aka samu monocyte (MMP) shine 0.17 ± 0.03 [2].
A cikin vivobincike Fondaparinux sodium yana da layin layi, bayanin martaba na pharmacokinetic mai dogaro da kashi, wanda ke ba da amsa mai faɗi sosai.Fondaparinux sodium yana da 100% bioavailability, yana da saurin fara aiki, yana da rabin rayuwar sa'o'i 14 zuwa 16, kuma yana iya ci gaba da tsayayya da thrombosis a cikin sa'o'i 24.Magungunan ba ya shafar lokacin prothrombin ko lokacin thromboplastin da aka kunna, kuma baya shafar aikin platelet ko tarawa [1].
Magana [1].Bauer KA.da al.Fondaparinux sodium: mai zaɓin mai hana factor Xa.Am J Health Syst Pharm.2001 Nov 1; 58 Suppl 2: S14-7.[2].Ben-Hadj-Khalifa S, et al.Tasirin hana haɓakar coagulation daban-daban na fondaparinux, enoxaparin da heparin marasa ƙarfi a cikin samfuran sel na ƙarni na thrombin.Jini Coagul Fibrinolysis.2011 Yuli; 22 (5): 369-73.

Sinadarai da kaddarorin jiki na Fondaparinux

Tsarin kwayoyin halitta Saukewa: C31H53N3Na10O49S8
Nauyin kwayoyin halitta 1738.16
PSA 900.82000

Fondaparinux wani sabon nau'in maganin antithrombotic ne wanda FDA ta amince da shi bayan heparin da ƙananan nauyin kwayoyin heparin don magani da rigakafin nau'in thrombosis na arteriovenous.

Alamomi: Ana amfani da Fondaparinux ga marasa lafiya da ke yin babban tiyatar orthopedic na ƙananan gaɓɓai, irin su karaya, babban tiyatar gwiwa ko maye gurbin hip, don hana thromboembolism venous.Ana amfani da shi don kula da marasa lafiya tare da angina maras tabbas ko marasa ƙarfi na ST-segment na haɓakar ƙwayar cuta na myocardial wanda ke yin gaggawa (<120 minutes) magani mai haɗari (PCI) ba tare da nuni ba.Ana amfani dashi don kula da marasa lafiya tare da ST-segment elevation myocardial infarction wanda ke amfani da thrombolysis ko da farko ba su karbi wasu nau'i na farfadowa na reperfusion ba.

1) Ci gaba da haɓaka kasuwa na Glaxo zai sanya shi a cikin ainihin matsayin magunguna a cikin hanyar asibiti na Ma'aikatar Lafiya ta gaba, sake fasalin farashin Hukumar Raya da Gyara ta ƙasa, da inshorar likita na Ma'aikatar Inshorar Jama'a.

A, Samfurin bai riga ya shiga inshorar likita na ƙasa ba.A cikin 2010, daidaitawar inshorar likita ya shiga cikin inshorar likitancin gida na larduna 16.Tallace-tallacen suna cikin matakin farko kuma a hankali za su maye gurbin kasuwar heparin mai ƙarancin ƙwayar cuta;lardunan inshorar likita: Shaanxi, Shanxi, Mongoliya ta ciki, Liaoning, Tibet, Yunnan, Guangdong, Guangxi, Hainan, Jiangsu, Gansu, Fujian, Jiangxi, Henan, Hubei, Beijing.

B, Alamun har yanzu suna karuwa.GSK a halin yanzu yana da alamomi 3 a cikin asibitin.Misali, alamun stent an yarda da su ne kawai.Sauran heparins ba su samuwa.Aikace-aikacen asibiti na stent yana ƙaruwa da 30% kowace shekara.Tare da amincewa da sababbin alamu, tallace-tallace zai karu.A cikin ka'idar, duk cututtukan da ake bi da su ta samfuran jerin samfuran heparin ana iya bi da su ta wannan samfurin.

C, Farashin fa'ida, mafi ƙarancin farashin wannan samfurin a cikin kasuwar Amurka shine dalar Amurka 132 kowanne, a China yuan 168, farashin gida ba zai faɗi ba.Idan kun yi fitarwa, kasuwar duniya tana da faffadan sarari;

2) Ƙofar fasaha yana da girma, an haɗa albarkatun kasa a cikin matakai 75, kuma alamar ta ƙare don shekaru 5 (lalacewa a cikin 2014).Wasu masana'antun ba su amince da shi ba.Haɗin yana da matukar wahala.Ba za a yi shi a cikin ƙasa da shekaru 10 ba.Zagayowar yana da tsawo, mai wahala, da zuba jari.babba.Akwai 'yan fafatawa a cikin gida, kuma masu fafatawa na kasashen waje suna da tsadar albarkatun kasa.Manufarmu ita ce ci gaba da rage farashin kayan da aka yi da maye gurbin Glaxo a samar da albarkatun kasa.
An amince da Hengrui Pharmaceuticals Fondaparinux a matsayin kwaikwayo na farko a kasar Sin 2018.
Guangdong Runxing Biotechnology Co., Ltd. yana da fitarwa na shekara-shekara na kilogiram 210 na fondaparinux sodium ci-gaba na matsakaicin N3, wanda za a gabatar a cikin 2018.

MYLAN IRELAND ne ya kirkiro Fondaparinux.A halin yanzu, Hengrui Pharmaceuticals, Borui Pharmaceuticals, Haisco.

Don zama matakin tabbatar da mafarki na ma'aikatan mu!Don gina farin ciki, ƙarin haɗin kai da ƙarin ƙwararrun ƙungiyar!Don samun lada tare da masu siyayya, masu siyarwa, jama'a da kanmu don Low MOQ don Siyarwa mai zafi!Samar da Factory High Quality Betrixaban Raw Materials CAS 330942-05-7, Mu masu gaskiya ne kuma bude.Muna sa ido ga tsayawa ta hanyar kafa amintacciyar dangantakar soyayya mai dorewa.
Low MOQ donChina Pharmaceutical Matsakaicin da 330942-05-7, "Kyakkyawan inganci da farashi mai kyau" sune ka'idodin kasuwancin mu.Idan kuna sha'awar mafitarmu ko kuna da wasu tambayoyi, ku tuna don jin daɗin tuntuɓar mu.Muna fatan kulla alakar hadin gwiwa da ku nan gaba kadan.


  • Na baya:
  • Na gaba:

  • Ku rubuta sakonku anan ku aiko mana